Open AccessThe role of trabectedin as second-line treatment of advanced soft tissue sarcoma: update of key efficacy and safety data
Author(s) -
Axel Le Cesne
Publication year - 2022
Publication title -
future oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.857
H-Index - 72
eISSN - 1744-8301
pISSN - 1479-6694
DOI - 10.2217/fon-2022-0516
Subject(s) - trabectedin , medicine , soft tissue sarcoma , oncology , soft tissue , key (lock) , sarcoma , first line , surgery , pathology , computer science , computer security